Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44

Molecular Cell

Volumn 13, Issue 4, 2004, Pages 483-496

  Teriete, Peter ^a,b   Banerji, Suneale ^c   Noble, Martin ^a,b   Blundell, Charles D ^a,b   Wright, Alan J ^a,b   Pickford, Andrew R ^b   Lowe, Edward ^a,b   Mahoney, David J ^a   Tammi, Markku I ^d   Kahmann, Jan D ^a,b   Campbell, Iain D ^b   Day, Anthony J ^a   Jackson, David G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; HERMES ANTIGEN; HYALURONIC ACID;

ARTICLE; CELL SURFACE; LECTIN BINDING SITE; LYMPHOCYTE HOMING; LYMPHOCYTIC INFILTRATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLASMA PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; ANTIGENS, CD44; CONSERVED SEQUENCE; CRYSTALLOGRAPHY, X-RAY; CYSTEINE; HYALURONIC ACID; HYDROGEN BONDING; INFLAMMATION; LEUKOCYTES; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID; SOLUBILITY;

EID: 10744221425     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(04)00080-2     Document Type: Article

References (51)

1. Aruffo A., Stamenkovic I., Melnick M., Underhill C.B., Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 61:1990;1303-1313.
2. Bajorath J., Greenfield B., Munro S.B., Day A.J., Aruffo A. Identification of CD44 residues important for hyaluronan binding and delineation of the binding site. J. Biol. Chem. 273:1998;338-343.
3. Banerji S., Day A.J., Kahmann J.D., Jackson D.G. Characterization of a functional hyaluronan-binding domain from the human CD44 molecule expressed in Escherichia coli. Protein Expr. Purif. 14:1998;371-381.
4. Banerji S., Ni J., Wang S.-X., Clasper S., Su J., Tammi R., Jones M., Jackson D.G. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144:1999;789-801.
5. Bartolazzi A., Peach R., Aruffo A., Stamenkovic I. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J. Exp. Med. 180:1994;53-66.
6. Blundell C.D., Mahoney D.J., Almond A., DeAngelis P.L., Kahmann J.D., Teriete P., Pickford A.R., Campbell I.D., Day A.J. The Link module from ovulation-associated protein TSG-6 changes conformation on hyaluronan binding. J. Biol. Chem. 278:2003;49261-49270.
7. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S.et al. Crystallography & NMR system. a new software suite for macromolecular structure determination Acta Crystallogr. D Biol. Crystallogr. 54:1998;905-921.
8. CCP4 Collaborative Computational Project, Number 4) The CCP4 suite. programs for protein crystallography Acta Crystallogr. D. 50:1994;760-763.
9. Day A.J., Prestwich G.D. Hyaluronan-binding proteins. tying up the giant J. Biol. Chem. 277:2002;4585-4588.
10. De Grendele H.C., Estess P., Siegelman M.H. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science. 278:1997;672-675.
11. English N.M., Lesley J.F., Hyman R. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding. Cancer Res. 58:1998;3736-3742.
12. Gee K., Kozlowski M., Kumar A. TNFα induces functionally active hyaluronan-adhesive CD44 by activating silidase through p38 mitogen-activated protein kinase in lipopolysaccharide-stimulated human monocytic cells. J. Biol. Chem. 278:2003;37275-37287.
13. Goddard, T.D., and Kneller, D.G. (2003). SPARKY (University of California, San Francisco), www.cgl.ucsf.edu/home/sparky/
14. Holm L., Sander C. Protein structure comparison by alignment of distance matrices. J. Mol. Biol. 233:1993;123-138.
15. Jackson D.G. The lymphatics revisited. new perspectives from the hyaluronan receptor LYVE-1 Trends Cardiovasc. Med. 13:2003;1-7.
16. Jackson D.G., Prevo R., Clasper S., Banerji S. LYVE-1, the lymphatic system and tumor angiogenesis. Trends Immunol. 22:2001;317-321.
17. Jones T.A., Zou J.Y., Cowan S.W., Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A. 47:1991;110-119.
18. Kahmann J.D., O'Brien R., Werner J.M., Heinegard D., Ladbury J.E., Campbell I.D., Day A.J. Localization and characterization of the hyaluronan-binding site on the Link module from human TSG-6. Structure. 8:2000;763-774.
19. Katoh S., Zheng Z., Oritani K., Shimozato T., Kincade P. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J. Exp. Med. 182:1995;419-429.
20. Katoh S., Miyagi T., Taniguchi H., Matsubara Y., Kadota J., Tominaga A., Kincade P.W., Matsukura S., Kohno S. An inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes. J. Immunol. 162:1999;5058-5061.
21. Katoh S., Matsumoto N., Kawakita K., Tominaga A., Kincade P., Matsukura M. A role for CD44 in an antigen-induced murine model of pulmonary eosinophilia. J. Clin. Invest. 111:2003;1563-1570.
22. Kincade P.W., Zheng Z., Katoh S., Hanson L. The importance of cellular environment to function of the CD44 matrix receptor. Curr. Opin. Cell Biol. 9:1997;635-642.
23. Kohda D., Morton C.J., Parkar A.A., Hatanaka H., Inagaki F.M., Campbell I.D., Day A.J. Solution structure of the link module. a hyaluronan binding domain involved in extracellular matrix stability and cell migration Cell. 86:1996;767-775.
24. Laskowski R.A., Rullmannn J.A., MacArthur M.W., Kaptein R., Thornton J.M. Aqua and procheck-nmr. programs for checking the quality of protein structures solved by nmr J. Biomol. NMR. 8:1996;477-486.
25. Lesley J., Kincade P.W., Hyman R. Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody. Eur. J. Immunol. 23:1993;1902-1909.
26. Lesley J., English N., Perschl A., Gregoroff J., Hyman R. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J. Exp. Med. 182:1995;431-437.
27. Lesley J., Hyman R., English N., Catterall J.B., Turner G.A. CD44 in inflammation and metastasis. Glycoconj. J. 14:1997;611-622.
28. Lesley J., Hascall V., Tammi M., Hyman R. Hyaluronan binding by cell surface CD44. J. Biol. Chem. 275:2000;26967-26975.
29. Levesque M.C., Haynes B.F. TNFα and IL-4 regulation of hyaluronan binding to monocyte CD44 involves posttranslational modification of CD44. Cell. Immunol. 193:1999;209-218.
30. Liao H.-X., Lee D.M., Levesque M.C., Haynes B. N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding. J. Immunol. 155:1995;3938-3945.
31. Mahoney D.J., Aplin R.T., Calabro A., Hascall V.C., Day A.J. Novel methods for the preparation and characterization of hyaluronan oligosaccharides of defined length. Glycobiology. 11:2001;1025-1033. a.
32. Mahoney D.J., Blundell C., Day A.J. Mapping the hyaluronan binding site on the Link module from human tumour necrosis factor-stimulated gene-6 by site-directed mutagenesis. J. Biol. Chem. 276:2001;22764-22771. b.
33. Mikecz K., Brennan F.R., Kim J.H., Glant T.T. Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis. Nat. Med. 1:1995;558-563.
34. Mohamadzadeh M., DeGrendele H., Arizpe H., Estess P., Siegelman M. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. J. Clin. Invest. 101:1998;97-108.
35. Moody A.M., Chui D., Reche P.A., Priatel J.J., Marth J.D., Reinherz E.L. Developmentally regulated glycosylation of the CD8αβ coreceptor stalk modulates ligand binding. Cell. 107:2001;501-512.
36. Noble P.W. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol. 21:2002;25-29.
37. Panchal S.C., Bhavesh N.A., Hosur R.V. Improved 3D triple resonance experiments, HNN and HN(C)N, for HN and 15N sequential correlations in (13C, 15N) labeled proteins. application to unfolded proteins J. Biomol. NMR. 2:2001;135-147.
38. Peach R.J., Hollenbaugh D., Stamenkovic I., Aruffo A. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol. 122:1993;257-264.
39. Pickford A.R., Smith S.P., Staunton D., Boyd J., Campbell I.D. The hairpin structure of the (6)F1(1)F2(2)F2 fragment from human fibronectin enhances gelatin binding. EMBO J. 20:2001;1519-1529.
40. Pure E., Cuff C.A. A crucial role for CD44 in inflammation. Trends Mol. Med. 7:2001;213-221.
41. Shaka A.J., Barker P.B., Freeman R. Computer optimized decoupling scheme for wideband applications and low-level operation. J. Magn. Reson. 64:1985;547-552.
42. States D.J., Haberkorn R.A., Ruben D.J. A 2-dimensional nuclear Overhauser experiment with pure phase in 4 quadrants. J. Magn. Reson. 28:1982;286-292.
43. Takeda M., Terasawa H., Sakakura M., Yamaguchi Y., Kajiwara M., Kawashima H., Miyasaka M., Shimada I. Hyaluronan recognition mode of CD44 revealed by cross-saturation and chemical shift perturbation experiments. J. Biol. Chem. 278:2003;43550-43555.
44. Tammi M.I., Day A.J., Turley E.A. Hyaluronan and homeostasis. a balancing act J. Biol. Chem. 277:2002;4581-4584.
45. Terwilliger T.C., Berendzen J. Automated MAD and MIR structure solution. Acta Crystallogr. D Biol. Crystallogr. 55:1999;849-861.
46. Toole B.P., Wight T.N., Tammi M.I. Hyaluronan-cell interactions in cancer and vascular disease. J. Biol. Chem. 277:2002;4593-4596.
47. Weiss L., Slavin S., Reich S., Cohen P., Shuster S., Stern R., Kaganovsky E., Okon E., Rubinstein A.M., Naor D. Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody. Proc. Natl. Acad. Sci. USA. 97:2000;285-290.
48. Weiss M.S., Sicker T., Djinovic-Carugo K., Hilgenfeld R. On the routine use of soft X-rays in macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 57:2001;689-695.
49. Wishart D.S., Sykes B.D. The 13C chemical-shift index. a simple method for the identification of protein secondary structure using 13C chemical-shift data J. Biomol. NMR. 4:1994;171-180.
50. Xu Z., Weiss A. Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nat. Immunol. 3:2002;764-771.
51. Zheng Z., Katoh S., He Q., Oritani K., Miyake K., Lesley J., Hyman R., Hamik A., Parkhouse R.M.E., Farr A.G., Kincade P.W. Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J. Cell Biol. 130:1995;485-495.